ClinicalTrials.Veeva

Menu

Timing of Oocyte Retrieval and Micro Testicular Sperm Extraction

O

Ovo Clinic

Status

Completed

Conditions

Microdissection Testicular Sperm Extraction

Study type

Observational

Funder types

Industry

Identifiers

NCT07268235
Micro-TESE

Details and patient eligibility

About

This is a retrospective study to assess outcomes of micro-TESE performed 24 or 48 hours before oocyte retrieval and ICSI.

Full description

This retrospective study evaluates patients undergoing ICSI following micro-TESE. Participants are assigned to two groups based on the interval between sperm extraction and oocyte retrieval (24 vs. 48 hours). Clinical and embryological outcomes from the first embryo transfer will be assessed.

Enrollment

129 patients

Sex

Male

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Men who underwent a micro-TESE at the OVO clinic from June 2015 to January 2025.
  • Patients with non-obstructive azoospermia (NOA), (absence of spermatozoa in multiple semen analyses)
  • Patients with cryptozoospermia, (presence of a small number of spermatozoa detectable only after semen centrifugation)
  • Patients with oligoasthenoteratozoospermia (OAT), (sperm concentration of less than 15 million/mL, reduced motility and abnormal morphology)

Exclusion criteria

  • Patients who did not have any sperm noted following micro-TESE
  • Use of donor sperm or oocytes
  • Frozen sperm or oocytes
  • Same day oocyte retrieval and sperm extraction
  • Reversible cause of cryptozoospermia (i.e presence of a varicocele, febrile illness, or recent toxin exposure) Partial genital tract obstruction (i.e post-vaso-vasostomy, post-vasoepididymostomy, and low volume cryptozoospermia with ejaculatory duct obstruction)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems